Historically it has been accepted, and recent research has established, that silver (Ag) is an efficacious antimicrobial agent. A dwindling pipeline of new antibiotics, combined with an increase in the number of antibiotic-resistant infections, is bringing Ag to the fore as a therapeutic compound to treat infectious diseases. Currently, many formulations of Ag are being deployed for commercial and medical purposes, with various degrees of effectiveness at killing microbial cells. H istory has demonstrated that silver (Ag) is an efficacious antimicrobial agent, finding utility as an antiquated preservative for food and water (1, 2). Currently, Ͼ100 Ag-containing medical devices have been approved for use by the FDA (http: //www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn .cfm), and there is mounting evidence that Ag may be effective for preventing the spread of infectious disease (1, 3, 4) . Although the toxicological profile of orally administered Ag remains to be resolved, topical application for the treatment of chronic wounds remains promising (5-8). Accordingly, Ag can address a timely public health issue, as chronic wounds represent a substantial financial and medical burden to the health care system. One of the hallmarks of a chronic wound is the presence of a biofilm, a factor that complicates wound healing and is hypothesized to be the fulcrum between the acute-to-chronic-wound transition (6, 9-15). Also, bacterial biofilms contaminate implanted medical devices (16) and exhibit high-level resistance to conventional antibiotics (17-23). New antibiofilm agents are thus desperately needed in medicine.
H
istory has demonstrated that silver (Ag) is an efficacious antimicrobial agent, finding utility as an antiquated preservative for food and water (1, 2) . Currently, Ͼ100 Ag-containing medical devices have been approved for use by the FDA (http: //www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn .cfm), and there is mounting evidence that Ag may be effective for preventing the spread of infectious disease (1, 3, 4) . Although the toxicological profile of orally administered Ag remains to be resolved, topical application for the treatment of chronic wounds remains promising (5) (6) (7) (8) . Accordingly, Ag can address a timely public health issue, as chronic wounds represent a substantial financial and medical burden to the health care system. One of the hallmarks of a chronic wound is the presence of a biofilm, a factor that complicates wound healing and is hypothesized to be the fulcrum between the acute-to-chronic-wound transition (6, (9) (10) (11) (12) (13) (14) (15) . Also, bacterial biofilms contaminate implanted medical devices (16) and exhibit high-level resistance to conventional antibiotics (17) (18) (19) (20) (21) (22) (23) . New antibiofilm agents are thus desperately needed in medicine.
Recently, researchers have demonstrated that Ag formulations also have potential as antibiofilm agents; these formulations include silver sulfadiazine (AgSD) (24) , Ag nanoparticles (AgNPs) (25, 26) , and silver nitrate (AgNO 3 ) (27) . Currently, the wound care industry is replete with Ag-based ointments and wound dressings with claimed efficacy at reducing bacterial bioburden (7, (28) (29) (30) (31) (32) . However, only a few antibiofilm products exist. There are numerous reasons why this is so: (i) current standardized, antimicrobial testing methods focus on bacteria in their planktonic state and not as biofilms (33, 34) ; (ii) biofilms are characteristically more tolerant to metal poisoning (35) (36) (37) (38) ; and (iii) the detailed mechanism of action for the toxicity of Ag to biofilms remains to be fully described (1) .
The antimicrobial activity of Ag is intrinsically dependent on the formation of the Ag 1ϩ ion (7, 39) . Briefly, Ag 1ϩ , a Lewis soft acid, poisons the microbial cell by binding to reduced thiols (SH), impairing membrane function (1) , and disrupting ironsulfur clusters (40) . That being said, the antimicrobial efficacy of higher oxidation states of Ag, Ag 2ϩ and Ag 3ϩ , has not been given adequate consideration, mainly due to instability in solution. A promising resolution to the instability of higher oxidation states of Ag is silver oxysalts, for example, Ag(Ag 3 O 4 ) 2 X, the most stable of which is coordinated with nitrate, silver oxynitrate [Ag(Ag 3 O 4 ) 2 NO 3 or Ag 7 NO 11 ], where both the Ag(II) and Ag(III) oxidation states exist stably at room temperature (41, 42) . Here, we describe our observations from testing the antimicrobial and antibiofilm activities of various metal compounds. Namely, we tested Ag 7 NO 11 , AgSD, AgNO 3 , silver sulfate (Ag 2 SO 4 ), silver-(I,III) oxide (AgO), silver(I) oxide (Ag 2 O), and copper sulfate (CuSO 4 ) against 6 bacterial strains, Pseudomonas aeruginosa (strain PAO1), Staphylococcus aureus (ATCC 25923), Escherichia coli (JM109), uropathogenic Escherichia coli (UPEC) (CFT703), fluoroquinolone-resistant Pseudomonas aeruginosa (FQRP), and methicillin-resistant Staphylococcus aureus (MRSA) (USA300), as well as two fungal strains, Candida albicans (ATCC 14053) and Candida tropicalis (99916). CuSO 4 was included in our analysis because copper (Cu) is another thiophilic metal with observed antimicrobial activity (1, 43, 44) . Using the minimal biofilm eradication concentration (MBEC) assay, we found that Ag 7 NO 11 eradicated planktonic and biofilm populations of the tested strains at lower concentrations than those of the other metal compounds tested. AgNO 3 , the most soluble Ag salt, also had antimi-crobial and antibiofilm activity at micromolar concentrations. Because AgNO 3 has high solubility, resulting in easily accessible Ag ϩ ions, and it outperformed all other Ag salts with the exception of Ag 7 NO 11 , it was chosen as our comparator for testing of the efficacy of Ag 7 NO 11 in the proceeding experiments. Using the live/ dead staining technique as well as crystal violet staining, we demonstrated that Ag 7 NO 11 reduced the biomass of the biofilm. In summary, our data demonstrate that Ag 7 NO 11 has greater antimicrobial and antibiofilm activity than do the other tested metal compounds and may offer an alternative option for the treatment of chronic wounds infected by biofilm-forming microbes. (31, 45) was used as the growth medium and for susceptibility testing.
MATERIALS AND METHODS

Bacterial
Biofilm formation. All biofilms used in this study were cultivated by using the Calgary Biofilm Device (CBD)/MBEC device as previously described (38, (46) (47) (48) (49) (50) and according to the manufacturer's guidelines (Innovotech, Edmonton, AB, Canada). Briefly, following growth of the preculture overnight, the colonies were suspended in SWF to match the density of a 1.0 McFarland standard. The cultures made with the optical standard were subsequently diluted 30 times in 150 l of SWF, which served as the inoculum for the CBD. The biofilm was formed by placing the lid of the CBD, with 96 equivalent pegs, into a 96-well microtiter plate (Nunclon; VWR International) containing the inoculum. The CBD was then placed on a gyratory shaker operating at 150 rpm in a humidified incubator at 37°C for 4 h or 24 h. For mature biofilm experiments, the inoculated CBD was incubated for a period of 4 days (P. aeruginosa) or 6 days (S. aureus and E. coli). A period exceeding 4 days resulted in overgrowth of PAO1 in the MBEC device (personal observation).
Stock metal solutions. AgNO 3 , AgSD, Ag 2 SO 4 , Ag 2 O, AgO, and CuSO 4 were all obtained from Sigma-Aldrich (St. Louis, MO, USA). Ag 7 NO 11 was obtained from Exciton Technologies Inc. (Edmonton, AB, Canada). All stock Ag solutions were made at equivalent molarities of Ag (up to 5 mM) in distilled and deionized water (ddH 2 O). The CuSO 4 stock was made up to 2 M in ddH 2 O. All metal solutions were stored in glass vials at 21°C for no longer than 1 week. Working solutions were made in SWF, from the stock metal solution, no more than 30 min prior to experimental use. From these solutions, serial dilutions (dilution factor of 2) were made in 96-well plates (challenge plate). The first row was reserved as a sterility control, and the second row was used as a growth control (0 mM metal salt). The range of concentrations tested for all Ag compounds was 0 to 1,250 M, while CuSO 4 was tested at concentrations of 0 to 20,000 M.
Biofilm and planktonic culture susceptibility testing. Two scenarios were tested: (i) the capacity of metal salts to prevent biofilm formation and (ii) the ability of metal salts to eradicate established biofilms. For the first scenario, the bacterial cultures were inoculated into the challenge plate in the presence of the metal salts and then subsequently placed onto a gyratory shaker at 150 rpm in a humidified incubator at 37°C for 4 h. The second scenario allowed for the establishment of a biofilm for 24 h, 4 days, or 6 days on the pegged lid of the CBD. The pegged lid containing the established biofilm was then rinsed twice with 0.9% NaCl and subsequently placed into the 96-well microtiter plate containing 2-fold serial dilutions of the challenge metal (challenge plate). The plate was then incubated for 4 h, 24 h, or 48 h on a gyratory shaker at 150 rpm in a humidified incubator at 37°C.
To test the metal susceptibility of the planktonic and biofilm populations, the plates from the first and second scenarios were prepared by removing the pegged lid and rinsing it twice with 0.9% NaCl. The biofilms were disrupted from the pegs by sonication using a 250HT ultrasonic cleaner (VWR International), set at 60 Hz for 10 min, into 200 l of tryptic soy broth (VWR International) containing universal neutralizer (UN) (0.05 g/liter histidine [Sigma, USA], 0.05 g/liter cysteine [Sigma, USA], and 0.l g/liter reduced glutathione [Sigma, USA] in ddH 2 O) and 0.1% Tween 20. The MBEC of the biofilm populations was ascertained by performing 8 dilutions (dilution factor of 10) of the disrupted biofilms in 0.9% NaCl. The numbers of viable cells from the biofilm were ascertained by spot plating the diluted sample onto TSA plates and subsequently inoculating the plates overnight at 37°C (36, 38, 51) . Similarly, determination of the minimal bactericidal concentration (MBC) of the planktonic populations was carried out by serially diluting (8 times [10-fold dilutions]) the neutralized (UN, as described above) spent medium from the 96-well plate into 0.9% saline. Viable cell counts were taken following spot plating of the dilutions onto TSA plates incubated overnight at 37°C (36, 38, 51) . The MBC and MBEC were determined by monitoring the concentration of metal compound at which there were no viable microbial colonies.
Confocal microscopy. Quantification of live and dead cells in the biofilm was performed by using a confocal microscope and the Live/Dead BacLight staining kit (Molecular Probes, Burlington, ON, Canada). Briefly, following metal exposure, cell viability staining of the bacteria was done by incubating the pegs containing the biofilms with Syto-9 (6.7 M) and propidium iodide (PI) (40 M) stains (provided in the BacLight kit) at 30°C for 30 min, as previously described (46) . The pegs were rinsed with 0.9% saline twice and monitored by using a confocal laser scanning microscope (Leica DM IRE2 microscope) equipped with a 20ϫ objective. Images were processed by using Imaris ϫ64 (Bitplane, USA). For PI, the excitation wavelength was set at 523 nm and the emission wavelength was set at 617 nm (red), while for Syto-9, the excitation wavelength was set at 488 nm and the emission wavelength was set at 498 nm (green). Quantification of the compiled confocal images was performed by using the Fiji software package (http://fiji.sc/Fiji).
Crystal violet assay. Crystal violet staining was used to quantify the amount of biomass in the biofilm. Following metal treatment, the pegged lids from the CBD were rinsed twice in 200 l of 0.9% saline. By using a procedure similar to the one described previously by O'Toole (52), the biofilms were stained with 200 l of a 0.1% crystal violet solution for 10 min. Following staining, the pegs were washed with 200 l ddH 2 O three times and blotted onto a paper towel to remove excess dye. The stain was left to set overnight at room temperature. Quantification of the biofilm was performed by solubilizing the crystal violet stain with 200 l of 30% acetic acid for 15 min into a microtiter plate and reading the absorbance at 550 nm using acetic acid as the blank.
Statistical analysis. The statistical significance of the results was determined by using nonparametric one-way analysis of variance (ANOVA) for the MBC and MBEC assays, two-way ANOVA for the crystal violet assays, or Student's t test for the data shown in Fig. S3 and S4 in the supplemental material. All experiments were performed, at minimum (stated otherwise in the figure legends), with two biological replicates and in duplicate.
RESULTS
Ag 7 NO 11 prevents biofilm formation. In order to assess the capacity of various metal compounds to prevent biofilm formation in our selected pathogenic strains (E. coli, P. aeruginosa, and S. aureus), we employed a MBEC assay (Fig. 1) . Concurrently, the MBC for the metal compounds was also established. Compared to the other metal compounds tested, significantly low concentrations of Ag 7 NO 11 were needed to prevent the formation of biofilms (Fig. 1A) and, with the exception of AgNO 3 , to eliminate planktonic populations of our tested strains (Fig. 1B) following a 4-h incubation period.
Ag 7 NO 11 eradicates established biofilm populations. Our next aim was to assess the capacity of various metal compounds to eradicate an established biofilm. Biofilms from E. coli, P. aeruginosa, and S. aureus were established following a 24-h incubation period in the MBEC device. The established biofilms were then exposed to serial dilutions (2-fold) of Ag 2 O, AgO, Ag 2 SO 4 , AgNO 3 , Ag 7 NO 11 , AgSD, and CuSO 4 for 24 h (Fig. 2) . A 4-h exposure of established biofilms to AgNO 3 , Ag 7 NO 11 , and CuSO 4 was an insufficient time to eradicate them (see Fig. S1 in the supplemental material), with the exception of E. coli biofilms. Thus, a 24-h exposure to the metal compounds was evaluated as a potentially efficacious treatment period. Following a 24-h incubation with the various metal compounds, we observed that Ag 7 NO 11 significantly reduced biofilm populations of E. coli, P. aeruginosa, and S. aureus at lower concentrations than those of the other tested metal compounds, with the exception of AgNO 3 in P. aeruginosa (Fig. 2) . When mature biofilms were established in the MBEC device, following a 4-day (P. aeruginosa) or 6-day (E. coli and S. aureus) period, higher concentrations of AgNO 3 , CuSO 4 , and Ag 7 NO 11 were required to reach the MBEC, with the exception of CuSO 4 in E. coli (Fig. 3) . Nonetheless, Ag 7 NO 11 eradicated the mature biofilms of S. aureus and E. coli at lower concentrations than those of AgNO 3 and CuSO 4 (Fig. 3) . Additionally, at the highest concentrations (of equivalent Ag) of AgNO 3 and Ag 7 NO 11 tested (1,250 M), Ag 7 NO 11 significantly outperformed AgNO 3 and CuSO 4 at eradicating C. albicans and C. tropicalis biofilms (see Fig. S2 in the supplemental material).
Ag 7 NO 11 reduces the biomass of established biofilms. Since AgNO 3 and Ag 7 NO 11 were most efficacious at eliminating planktonic populations, preventing biofilm formation, and eradicating established biofilms ( Fig. 1 and 2 ), these two metal compounds were chosen as lead compounds to study the capacity of Ag to abolish established biofilms. We employed live/dead staining followed by confocal microscopy analysis to visualize the effects of 4-h and 24-h treatments with 5 M and 12.5 M AgNO 3 and Ag 7 NO 11 (at equivalent Ag concentrations) on established biofilms of E. coli, P. aeruginosa, and S. aureus ( Fig. 4 ; see also in the supplemental material). Although a 4-h exposure to AgNO 3 and Ag 7 NO 11 was not adequate to eradicate the biofilm populations, an increase in the quantity of dead cells was observed in the biofilms exposed to 12.5 M AgNO 3 and Ag 7 NO 11 (see Fig. S3 in the supplemental material). Following a 24-h exposure to AgNO 3 and Ag 7 NO 11 , we observed an increase in the number of dead cells in the biofilms exposed to 12.5 M AgNO 3 and a reduction in biofilm quantity in the biofilms exposed to Ag 7 NO 11 ( Fig. 4 ; see also Fig. S4 in the supplemental material) . To confirm that Ag 7 NO 11 bestowed the capacity to reduce the quantity of the biomass in the biofilms, we performed a crystal violet staining assay, according to methods described previously by O'Toole (52), on established E. coli, P. aeruginosa, and S. aureus biofilms following a 24-h exposure to AgNO 3 , Ag 7 NO 11 , and CuSO 4 (Fig. 5) . We observed that Ag 7 NO 11 had significantly greater efficacy than did AgNO 3 and CuSO 4 at reducing the quantity of biomass in E. coli and P. aeruginosa biofilms, although much higher concentrations were needed to reduce the P. aeruginosa biofilm biomass (Fig. 5) . Meanwhile, Ag 7 NO 11 outperformed only CuSO 4 for reducing the biomass of S. aureus biofilms (Fig. 5) .
Ag 7 NO 11 is more efficacious against select clinical isolates and antibiotic-resistant strains of E. coli (UPEC [CFT703]), P. aeruginosa (FQRP), and S. aureus (MRSA [USA300]).
To demonstrate the potential of using Ag 7 NO 11 as an antimicrobial beyond laboratory strains of bacterial pathogens, we performed MBC and MBEC assays on UPEC, FQRP, and MRSA planktonic and biofilm populations, respectively, with serial dilutions of Ag 7 NO 11 , AgNO 3 , and CuSO 4 (Fig. 6, 7 , and 8, respectively). Our observations suggest that higher concentrations of AgNO 3 , Ag 7 NO 11 , and CuSO 4 are required to eradicate planktonic and biofilm populations of UPEC, FQRP, and MRSA ( Fig. 6 to 8) , with the one exception of Ag 7 NO 11 in FQRP, which has a similar effectiveness at eradicating planktonic populations as well as preventing and eradicating biofilm populations as it does in the PAO1 strain ( Fig. 7 and 1, respectively) . Nonetheless, we observed that Ag 7 NO 11 eliminated planktonic populations, prevented biofilm formation, and eradicated established biofilms of UPEC, FQRP, and MRSA at lower concentrations than those of AgNO 3 , and CuSO 4 , with the exception of established UPEC biofilms, which had no considerable log reduction values at the concentrations and treatment times tested (Fig. 6 to 8) . 
DISCUSSION
Biofilms represent an earnest concern in medicine, as they contribute to chronic infections, complicate wound healing, contaminate medical devices, and exhibit resistance to conventional antimicrobials (9, 16, 20, 21, (53) (54) (55) (56) (57) (58) . Ionic silver (Ag ϩ ) has a demonstrated antimicrobial outcome at low concentrations (59-61; see reference 62 and references therein) and may offer an alternative option for the treatment of antibiotic-resistant infections. Here, we demonstrated how Ag 7 NO 11 , a high-oxidationstate Ag compound, carries an enhanced antimicrobial and antibiofilm capacity. Additionally, our present study adds to the body of literature supporting the antimicrobial and antibiofilm potential of Ag.
In this study, we confirmed that Ag is effective at eliminating planktonic populations of E. coli, P. aeruginosa, and S. aureus. Additionally, we established that Ag is effective at preventing biofilm formation (Fig. 1 ) and eradicating established biofilms (Fig.  2) . Indeed, we also observed that Cu is effective at killing plank- (52), was performed on the biofilms. The biomass was quantified by measuring the absorbance at 550 nm. Values are represented as the means Ϯ standard deviations (n ϭ 15). Asterisks indicate a significant difference between CuSO 4 and Ag 7 NO 11 , where * indicates a P value of Յ0.05, ** indicates a P value of Յ0.01, *** indicates a P value of Յ0.001, and **** indicates a P value of Յ0.0001. Plus signs indicate a significant difference between AgNO 3 and Ag 7 NO 11 , where ϩ indicates a P value of Յ0.05, ϩϩ indicates a P value of Յ0.01, ϩϩϩ indicates a P value of Յ0.001, and ϩϩϩϩ indicates a P value of Յ0.0001. Note that all Ag stock solutions were prepared at equal molar concentrations of Ag molecules. Hence, concentrations found in this figure are reflective of the concentration of Ag and not the silver-containing compound itself. AU, arbitrary units. tonic and biofilm populations of laboratory pathogens albeit at millimolar concentrations. Mechanistically, both Cu and Ag are thiophilic metals that have similar targets in the microbial cell (1) . One key distinction between these two metals is that Cu is an essential metal, while Ag is nonessential and has no known function in bacterial cells (1) . However, it is important to recognize that the precise manner in which Ag poisons microbial cells remains to be fully elaborated.
One novel highlight of this study was that it demonstrated, for the first time, that Ag 7 NO 11 , a source of higher oxidation states of Ag, had a MBC and a MBEC that were much lower (2-fold or lower) than those of the other metal compounds tested. The advantage of having lower MBCs and MBECs is that less of the compound would be required for the desired therapeutic effect. Interestingly, Ag 7 NO 11 was not significantly better than AgNO 3 at preventing E. coli and P. aeruginosa biofilm formation or at eradicating established P. aeruginosa biofilms (Fig. 1A and 2) . However, Ag 7 NO 11 was significantly better than AgNO 3 at eradicating planktonic populations of all tested bacterial strains (Fig. 1B) . This observation is not surprising, as biofilms are notoriously more difficult to eliminate than are their planktonic counterparts (36, 51, 63, 64) , an observation confirmed by this study ( Fig. 1 and 2 ; see also Fig. S1 in the supplemental material). In terms of the MBC and MBEC of the Ag salts, the trend in efficacy appeared to follow the molar solubility of the salts in water: AgNO 3 Ͼ Ag 2 SO 4 Ͼ AgO Ͼ Ag 2 O (solubility product constant [Ksp] ϭ 51.6 M, 1.4 ϫ 10 Ϫ5 M, 4.8 ϫ 10 Ϫ8 M, and 3.6 ϫ 10 Ϫ11 M, respectively). However, we noted strain-specific sensitivities. For example, E. coli planktonic populations were more sensitive to Ag 2 SO 4 than were P. aeruginosa and S. aureus. We were surprised at the poor efficacy of AgSD, the silver-sulfonamide synergistic biocidal compound, as it is part of the current standard of care for the treatment of burn wounds (65) (66) (67) . In some cases, CuSO 4 outperformed AgSD as a bactericidal compound ( Fig. 1B and 2 ). Not surprisingly, much higher concentrations of and much longer treatment periods with Ag and Cu were needed to reduce the number of viable cells in mature biofilms (4 days for P. aeruginosa or 6 days for E. coli and S. aureus) (Fig. 3) . The enhanced metal resistance of mature biofilms has been reported previously (68) . However, making comparisons across studies is difficult due to differing methodologies used for growing the biofilms. Regardless, this study demonstrated that Ag 7 NO 11 outperformed AgNO 3 and CuSO 4 for eradicating mature E. coli and S. aureus biofilms.
A universally recognized challenge in treating biofilm-associated infections is reducing the biomass of the biofilm. Without a reduction of the biofilm biomass, many antimicrobials will kill the outermost bacteria in the biofilm but will fail to penetrate and kill the innermost bacterial cells, resulting in recurring or persistent infections (9, (69) (70) (71) increased the amount of dead cells within the biofilm, but Ag 7 NO 11 was superior for reducing the biomass of the biofilm ( Fig. 4; (Fig. 4) . Interestingly, while the biomass-reducing effects of the metal compounds on E. coli biofilms were concentration dependent, this was not the case with P. aeruginosa or S. aureus. This phenomenon raises interesting insights into the potential necessity to target therapies toward particular infections. However, no conclusions should be drawn from these limited observations.
Our overarching goal was to demonstrate the universal antimicrobial and antibiofilm potential of Ag 7 NO 11 . Accordingly, we performed MBC and MBEC assays on three clinically relevant pathogenic strains, uropathogenic E. coli, fluoroquinolone-resistant P. aeruginosa, and methicillin-resistant S. aureus (Fig. 6 to 8) , as well as MBEC assays on two laboratory strains of fungi, C. albicans and C. tropicalis (see Fig. S2 in the supplemental material). Again, Ag 7 NO 11 had a low MBC against planktonic populations, prevented biofilm formation, and eradicated established biofilms at lower concentrations than those of AgNO 3 and CuSO 4 . Certainly, Ag has been explored as a strategy to control infection by uropathogens (72) as well as to combat and control antibioticresistant pathogens, including MRSA (67, (73) (74) (75) (76) . The results from this study demonstrated variable sensitivities of the planktonic and biofilm populations to CuSO 4 , AgNO 3 , and Ag 7 NO 11 . In general, all of the planktonic and biofilm populations of the clinically relevant strains were capable of tolerating higher concentrations of the tested metals than those tolerated by their laboratory counterparts (Fig. 1, 2 , and 6 to 8). The single exception to this trend was observed with FQRP, where Ag 7 NO 11 was exceptionally efficacious in the low-micromolar range, tempting speculation that Ag 7 NO 11 can be used as an antimicrobial coating for endotracheal tubes. It is also noteworthy that Ag 7 NO 11 eliminated planktonic populations, prevented biofilm formation, and eradicated established biofilms at lower concentrations than those of AgNO 3 and CuSO 4 , with the exception of established UPEC biofilms, which could not be reduced to a significant level by Ag under the conditions tested, again confirming the challenge involved in eradicating an established biofilm. Although only limited analyses were performed in this study, we observed that Candida sp. biofilms are also difficult to eradicate (see Fig. S4 in the supplemental material). The enhanced tolerance of Candida sp. has been observed previously by our research group (38, 77, 78) . However, Ag 7 NO 11 still has a MBEC in the millimolar range, much within a potentially therapeutic range. This is ever important, as Candida species are biofilm-forming microorganisms with the potential to be infectious and can cause deleterious health outcomes (79) (80) (81) (82) .
To conclude, we have demonstrated here that thiophilic metals, such as Cu and Ag, are efficacious antimicrobial and antibiofilm agents. Furthermore, we have demonstrated that Ag 7 NO 11 , a compound that delivers higher oxidation states of Ag, has a greater antimicrobial and antibiofilm capacity, at equal concentrations of Ag, than do AgNO 3 , Ag 2 SO 4 , AgO, Ag 2 O, and CuSO 4 . Additionally, we demonstrated that Ag 7 NO 11 reduces the biomass of biofilms, an important strategy for combating biofilm-associated infections.
Recent realizations have focused on biofilms as the causative agent of many infectious diseases, but we are at a loss for adequate therapies to eradicate them. This includes chronic wounds, where many wound care products exist but very few have an antibiofilm capacity. Fortunately, wound care products offer the greatest potential for implementing metal-based antimicrobials, due to decreased internalization of the therapeutic by the patient. This is the venue for which we envision the best utility for Ag 7 NO 11 as a strategy for preventing and controlling infectious disease. Thus, Ag 7 NO 11 will add to our arsenal for combating infection, an arsenal that is desperately needed in the face of increasing numbers of antibiotic-resistant infections and a dwindling pipeline of new antibiotics. ETI manufactured and supplied the silver oxynitrate. In addition, ETI provided technical assistance in performing some of the experiments.
